DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples